On what inspired him to become a scientist.

​

On what made Jim a successful scientist.

MD Anderson research associate on her experience working in Jim's lab.

Cancer survivor on her road to leading a healthy life.

Texas Monthly journalist on Jim’s unique scientific process and the importance of basic science.

Parker Institute CEO on how far cancer immunology has come and his hopes for the field.

GIOVANNI CAFORIO

Bristol-Myers Squibb CEO discusses importance of diversity and passion in science.

MD Anderson scientist on how his father's illness inspired him to study immunology.

Former BMS scientific director on Jim’s impact on the ipi team.

MD Anderson clinician on immunotherapy and playing music with Jim.

MIT Professor on his experience studying cancer.

Former UT Austin Professor on Jim's graduate school application.

Former VP at BMS on his experience working on ipilimumab and immunotherapy drugs.

UC San Francisco Professor on his experience working in Jim's lab at Berkeley.

UC San Francisco Professor on his relationship with Jim and being outsiders in the field of cancer research.

DAN LITTMAN

NYU Professor on scientific communities around the world.

Former Senior VP at BMS on developing ipilimumab and meeting a patient.

Genetech VP of Cancer Immunology on the history and prospects of immunotherapy.

Former New York Times journalist on the evolution of cancer treatments.

UC Berkeley Professor on being recruited by Jim and working on the frontiers of immunology.

New York Times reporter on the evolution of the immune system and the difficulty of treating cancer.

MD Anderson scientist on coming to America and falling in love with science.

Former BMS executive on the difficulties developing ipilimumab.

Nobel laureate and former Memorial Sloan Kettering President on recruiting Jim.

Oncologist on Jim's impact on improving melanoma life expectancy.